Federal Appeals Court Dismisses Cancer Patients’ Case To Use Psilocybin Under Right-To-Try Laws

Marijuana Moment
By Ben AdlinFeb 1, 2022, 8:24 am244 pts
A three-judge panel of the U.S. Court of Appeals for the Ninth Circuit has rejected a lawsuit by cancer patients and their doctor seeking access to psilocybin—the main psychoactive compound in psychedelic mushrooms—to help treat end-of-life depression and anxiety. The patients and Seattle-based palliative care…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Curaleaf Q3 Revenue Falls 3% 78

Trulieve Reports $288M in Q3 Revenue, $27M Net Loss 77

Pro-Cannabis Democrat Mikie Sherrill Wins NJ Governorship 77

Green Thumb Industries Q3 Revenue Grows 2% 77

Marijuana Arrests Comprised Nearly Half of All Drug-Related Arrests in Over a Dozen States in 2024 76

Canadian cannabis producers disappointed by Budget 2025 proposals 76

AGLC provides updates to farmgate rules 76

Drinking Cannabis Beverages Reduces Alcohol Use And Improves Sleep, Stress And Mood, New Study Shows 74

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.